Israel’s Foamix has reported good results from the Phase II trials of its FMX103 treatment for papulopustular rosacea. The condition, suffered by millions, is characterized by facial redness from inflamed lesions.
Rosacea treatment is safe and effective
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.